Proshares Merger

Epoch Investment Partners Inc. Reduced Holdings in Kenvue Inc. in Q2

Canadian Government Approves Anglo's Proposed Acquisition of Teck Resources

Teck Resources' stock breaks above 50-day moving average, Q3 EPS at CAD 0.57

Nik Modi Maintains Hold Rating on Kenvue

Jefferies Maintains Hold Rating on Avadel Pharmaceuticals

Scotiabank reduces Teck Resources target price to 60.00 CAD

Teck board recommends shareholders vote in favor of merger

Canadian Industry Minister to Conduct National Security Review of Teck Resources and Anglo American Merger

Several Institutions Release Buy and Hold Ratings for Axalta Coating Systems Stock

Warren Investment Advisors Increases Stake in Kenvue Inc.

Alkermes Increases Bid for Avadel Pharmaceuticals to $2.37 Billion

Alkermes Increases Bid for Avadel

RBC Capital analyst downgrades Axalta Coating Systems to hold

Canadian Industry Minister Considers Approving Anglo American's Acquisition of Teck Resources

Citadel Group Discloses Stake and Short Position in Avadel Pharmaceuticals plc

Citi Analyst Maintains Kenvue Hold Rating with Target Price at $18

Akzo Nobel and Axalta Reach $25 Billion Merger Agreement

Akzo Nobel Approaches Axalta for Merger

Civitas Resources Inc. Proposes Merger with SM Energy

Janus Henderson Discloses Position and Short Interest in Avadel Pharmaceuticals

SEVEN HILLS RLTY TR COM USD0.001 (S/R 04/12/2025)

SMX Security Matters

Polyrizon

Picard Medical

Synchronoss Tech

PharmaCyte Biotech

Q/C Tech

Rich Sparkle

Tradr 2X Long ASTS Daily ETF

Able View Global

KVUE

Epoch Investment Partners Inc. reduced its stake in Kenvue Inc. by 10.1% in Q2, selling 486,365 shares. Kenvue's stock has a consensus "Hold" rating with a target price of $20.23. The stock opened at $16.97, with a market cap of $32.51 billion. Kenvue reported Q3 earnings of $0.28 per share, slightly above estimates, and announced a quarterly dividend of $0.2075 per share.

Market Beat

Kenvue

Epoch Investment Partners Inc. Sells 486,365 Shares of Kenvue Inc. $KVUE

CIVI

Civitas Resources Inc. has approved a new executive severance plan ahead of its merger with SM Energy Company. The plan extends change in control protection to 30 months for Tier 1-4 Executives and includes lump sum COBRA payments. Cash severance for Tier 1-3 Executives will be based on their base salary and a target annual bonus. If the merger does not proceed, the existing plan remains in place.

Reuters

SM Energy

Civitas Resources

Civitas Resources Announces Enhanced Executive Severance Plan Ahead of SM Energy Merger

The article highlights three top dividend aristocrat stocks recommended by Wall Street analysts: Kimberly-Clark Corporation, Chevron Corporation, and Kenvue Inc. These stocks are noted for their high dividend payout ratios and potential upside. Kimberly-Clark has a 22% upside potential, Chevron 17%, and Kenvue over 14%. The article suggests these stocks for investors seeking steady cash flow and provides insights into their dividend yields and analyst ratings.

Tip Ranks

Kimberly Clark

Chevron

3 Best Dividend Aristocrat Stocks to Buy Now, 12/4/2025

Kenvue Inc.'s stock fell 2.09% to $16.86 on Tuesday, underperforming the market despite favorable conditions, with the S&P 500 and Dow Jones rising. This marks the second consecutive day of losses for Kenvue, which is 33.02% below its 52-week high. Trading volume was 12.4 million below the 50-day average.

Dow Jones

Kenvue Inc. Stock Falls Tuesday, Underperforms Market

TD Securities upgraded New Gold (TSE:NGD) from a "hold" to a "buy" rating, raising the target price from C$7.50 to C$12.00. Other analysts also increased their price targets, with a consensus "buy" rating and an average target of C$10.61. The stock rose 2.5% to C$11.71. New Gold operates mines in Canada and Mexico, with revenue from gold, copper, and silver sales.

New GLD

New Gold (TSE:NGD) Upgraded by TD Securities to "Buy" Rating

RPTX

AXTA

Halper Sadeh LLC, an investor rights law firm, is investigating TreeHouse Foods, Repare Therapeutics, and Axalta Coating Systems for potential securities law violations. Shareholders are urged to contact the firm to discuss their rights, as Halper Sadeh may seek increased consideration or other relief on their behalf. The firm offers contingent fee arrangements, meaning no out-of-pocket legal fees for shareholders. Contact details are provided for further inquiries.

prnewswire

Repare Therapeutics

Treehouse Foods

Axalta Coating Systems LLC

12:39 ET
			
			
				Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights

Monteverde & Associates PC, a top securities class action firm, is investigating the fairness of several mergers: Repare Therapeutics' sale to XenoTherapeutics, Axalta's sale to Akzo Nobel, Wintergreen's merger with KIKA Technology, and Semrush's sale to Adobe. Shareholders are encouraged to seek more information and consider legal advice. The firm has a strong track record in recovering funds for shareholders.

23:13 ET
			
			
				HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - RPTX, AXTA, WTG and SEMR

New Gold Inc. highlighted its community engagement initiatives in its annual review, including quarterly meetings with stakeholders, educational programs, and partnerships with local institutions and Indigenous communities. The company emphasized its commitment to ongoing engagement and cultural awareness training for employees. This news brief was generated by AI and is for informational purposes only.

New Gold Inc. Highlights Community Engagement Initiatives in Annual Review

RBC Capital's Nik Modi maintained a Hold rating on Kenvue, Inc. with a price target of $21.00. Kenvue's shares closed at $17.03. Modi, who covers the Consumer Defensive sector, has an average return of -5.6% and a 42.28% success rate. Canaccord Genuity also rated Kenvue as Hold, while Jefferies rated it as Buy.

RBC Capital Remains a Hold on Kenvue, Inc. (KVUE)

Kenvue Inc. (KVUE) shares rose 1.12% to $17.22 on Wednesday, outperforming the market with the S&P 500 Index up 0.69% and the Dow Jones Industrial Average up 0.67%. This marks the stock's fifth consecutive day of gains. Trading volume was 46.3M, above the 50-day average of 43.6M.

Kenvue Inc. Stock Rises Wednesday, Outperforms Market

Kimberly-Clark's bid for Kenvue has led to stock market speculation, with KMB shares dropping and Kenvue's rising. The market doubts KMB's ability to close the deal due to its weak balance sheet, suggesting potential for arbitrage. If the deal fails, KMB's stock may rise, and Kenvue could attract other buyers like Unilever or Procter & Gamble. Both UL and PG need growth catalysts, and Kenvue's product lineup complements their portfolios, with PG being a better fit due to its American base.

Baystreet

Unilever

Speculate on KMB, Kenvue, and Unilever

Kenvue Inc. (KVUE) shares rose 1.61% to $17.03 on Tuesday, marking the fourth consecutive day of gains. The stock outperformed the market, with the S&P 500 rising 0.91% and the Dow Jones Industrial Average increasing by 1.43%. Kenvue is currently 32.34% below its 52-week high of $25.17. Trading volume was 44.0 million, surpassing the 50-day average of 43.1 million.

Kenvue Inc. Stock Rises Tuesday, Outperforms Market

New Gold Inc. has outlined its production guidance for New Afton and Rainy River mines, projecting significant growth in gold and copper production by 2025. The company expects a 35% increase in gold and a 90% increase in copper production, with a decline in all-in sustaining costs by 65%. Sustainability efforts include a 15% reduction in greenhouse gas emissions and 33% female board representation. Indigenous employment is at 24%. The presentation was published on November 24, 2025.

New Gold Inc. unveils outlook highlighting gold and copper production growth and sustainability initiatives

Amer Sports and Kenvue Inc Lead the Bull Strangle Watch List for the Week

Barchart Option

Amer Sports

Amer Sports and Kenvue Inc Lead the Bull Strangle Watch List for the Week

Seaport Global maintained a Buy rating on Axalta Coating Systems with a price target of $43.00. UBS’s Joshua Spector also issued a Buy rating, while RBC Capital downgraded it to a Hold.

Seaport Global Keeps Their Buy Rating on Axalta Coating Systems (AXTA)